Meeting Wed, 10/20/2021 - 12:00 Drug Utilization Review Board Meeting Information

Date
Media
Edit Implementation Schedule September 2021
PDL Announcements September 2021
PDL Recommendations September 2021
New Drugs Edits September 2021
Agenda
DUR 08-20-21 Agenda
Minutes
DUR minutes 10-20-2021
Criteria
DUR Criteria
Conduent Reports
Media
Conduent Reports September 2021
DUR Criteria
Preferred Drug List Proposals - No New Criteria
Media
Angiotensin Receptor Blocker Combo September 2021
Angiotensin Receptor Blocker CCB Combo September 2021
Beta Adrenergic Blocker Diuretic Combo September 2021
CCB Dihydropyridines September 2021
CCB Non Dihydropyridine September 2021
Direct Renin Inhibitors September 2021
Dry Eye Disease Agents September 2021
Niacin Derivatives September 2021
PAH Agents ETRAs September 2021
PAH Agents ETRAs September 2021
PAH Agents Prostacylin Pathway Agonists Inhaled September 2021
PAH Agents Prostacyclin Pathway Agonists Oral September 2021
Sympatholytic Agents September 2021
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
ACEI and ACEI Diuretic Combo September 2021
ACEI CCB Combos September 2021
ADHD Methylphenidate Long Acting September 2021
ADHD Methylphenidate Short Acting September 2021
ADHD Amphetamines Short Acting September 2021
ADHD Amphetamines Long Acting September 2021
ADHD Non Stimulant Agents September 2021
Anticoagulant Agents Oral and Subcutaneous September 2021
Anticonvulsants Rescue Agents September 2021
Antiplatelet Agents September 2021
Homozygous Familial Hypercholesterolemia Agents September 2021
PAH Agents PDE5 and SGC Stimulators September 2021
PAH Agents Prostacyclin Pathway Agonists Injectable September 2021
PCSK9 Inhibitors September 2021
Proton Pump Inhibitors September 2021
Statins and Combinations September 2021
Triglyceride Lowering Agents September 2021
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
Emsam September 2021
Immunoglobulins September 2021
Lambert Eaton Myasthenic Syndrome September 2021
Neuromyelitis Optica Spectrum Disorder September 2021
Nuedexta September 2021
Oxandrin September 2021
Palforzia September 2021
Ranexa September 2021
Transthyretin Mediated Amyloidosis September 2021
Xcopri September 2021
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
Aduhelm September 2021
Botulinum Toxin September 2021
Equetro September 2021
Narcolepsy Inhibitors September 2021
Psychotropic Medications Polypharmacy September 2021
Serotonin and Norepinephrine Reuptake Inhibitors September 2021
Selective Serotonin Reuptake Inhibitor September 2021
Page
Drug Utilization Review Board Meeting Information